Completed × Head and Neck Neoplasms × Dermatologic × Clear all Study of DF6215 in Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
MAGE-A10á¶â·âčâ¶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Phase 1 Completed
10 enrolled
AYAConnect
Phase NA Completed
63 enrolled
EARN
Phase NA Completed
33 enrolled
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
EDHITO
Phase NA Completed
411 enrolled
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Phase 1/2 Completed
307 enrolled 27 charts
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
Phase 1 Completed
146 enrolled 38 charts
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Phase 1 Completed
272 enrolled
Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer
Phase NA Completed
9 enrolled 9 charts
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
Phase 1 Completed
13 enrolled
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Completed
58 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
PREFER
Completed
1,429 enrolled
MOM
Completed
40 enrolled
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)
Phase 1/2 Completed
132 enrolled
DUET-3
Phase 1 Completed
198 enrolled
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Phase NA Completed
38 enrolled
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Phase 1 Completed
132 enrolled
AcSĂ©
Phase 2 Completed
269 enrolled
Topical Anaesthesia in Cutaneous Head and Neck Surgery
Phase NA Completed
124 enrolled
CHEERS
Phase 2 Completed
99 enrolled
Study of the CD40 Agonistic Monoclonal Antibody APX005M
Phase 1 Completed
43 enrolled
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Phase 1 Completed
37 enrolled
G-DEFINER
Completed
247 enrolled
A Study of PRT1419 in Patients With Advanced Solid Tumors
Phase 1 Completed
26 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
GASVERT
Phase 3 Completed
744 enrolled
DUET-2
Phase 1 Completed
150 enrolled
Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT
Phase NA Completed
9 enrolled
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Phase 1 Completed
17 enrolled 14 charts
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Phase NA Completed
9 enrolled
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Phase 1 Completed
174 enrolled 68 charts
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Phase 1 Completed
159 enrolled
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
Phase 1/2 Completed
444 enrolled 19 charts
Safety Study of MGA271 in Refractory Cancer
Phase 1 Completed
179 enrolled
Investigator Initiated Phase 1 Study of TBI-1201
Phase 1 Completed
18 enrolled
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
Phase 2 Completed
24 enrolled 16 charts
Poly-ICLC
Phase 2 Completed
26 enrolled
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
Phase 1 Completed
Improving Goals of Care Discussion in Advanced Cancer Patients
Phase NA Completed
265 enrolled 9 charts
Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
Phase 1 Completed
92 enrolled
Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors
Phase 1 Completed
28 enrolled
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Phase 1 Completed
28 enrolled
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
Phase NA Completed
1,053 enrolled
EPAC
Phase NA Completed
213 enrolled 20 charts